CSE:DRUG - Post Discussion
Post by
AwareInvestor on Aug 31, 2022 8:54am
Bright Minds Begins Phase 1 Clinical Trials Focused On Treat
Phase 1 trials are officially underway for Bright Minds Biosciences and their lead product, referred to as BMB-101. The firm this morning revealed that it has dosed the first patient under the trial as it looks to find a treatment for Dravet Syndrome, among other medical indications.
Be the first to comment on this post